-
Despite foundering Dengvaxia launch, Sanofi puts up 13.2% vaccines growth in Q1
fiercepharma
May 03, 2017
Sanofi’s vaccines business leaned on strong performances from pediatric, flu and travel shots on the way to 13.2% growth in the first quarter—because it certainly couldn't depend on the foundering dengue vaccine Dengvaxia.
-
Bexsero gains propel GSK's vaccines unit to pharma-beating 16% growth in Q1
fiercepharma
May 02, 2017
With a new captain at the helm, GlaxoSmithKline maintained its vaccines momentum in the first quarter with 16% growth for the unit, thanks to standout sales from meningitis shots picked up in its Novartis deal.
-
Bavarian Nordic to produce vaccines with cell line from Valneva
fiercepharma
April 19, 2017
Bavarian Nordic has licensed a cell line from Valneva to help it manufacture vaccines based on its modified vaccinia Ankara (MVA) vaccine platform currently used on a smallpox shot and a cancer vaccine.
-
GSK consolidates DT and TT vax production in Hungary plant, adding 100 jobs
fiercepharma
March 14, 2017
With GlaxoSmithKline’s vaccines sales expanding, it figures it needs expanded production as well and some of that will happen at a 10-year-old plant in Hungary as well as Germany.
-
The end of China’s vaccine scandal? Some Chinese lawyers don’t think so
fiercepharma
March 08, 2017
Following up on China's high-profile vaccine scandal, a group of lawyers in the country are calling for more legislation to ensure vaccine safety.
-
GSK's vaccines access leads the pack, report says, as lagging Pfizer disputes findings
fiercepharma
March 08, 2017
For the first time, the public health watchdogs at the Access to Medicine Foundation have trained their microscopes specifically on vaccines and the companies that make them.
-
350 medical and patient groups write to Trump: ‘Vaccines are safe’
fiercepharma
February 15, 2017
Spooked by President Donald Trump’s skeptical stance on vaccines, more than 350 pro-vaccine groups decided to express their “unequivocal support for the safety of vaccines” in a letter to the president.
-
Witty's bet on vaccines pays off in GSK CEO's final full year
fiercepharma
February 13, 2017
After nearly 10 years at the CEO post for GlaxoSmithKline, Andrew Witty is handing over the reins to a company that has been reshaped with a vaccines focus. And during Witty’s final full year at the drugmaker, that business segment outgrew each of GSK’s o
-
Sartorius Stedim Biotech launches two Single-use Sartocon Loop Assemblies with Integrated Polyethers
pharmaasia
February 08, 2017
Assemblies save up to 60 percent on processing time and offer a safe approach to ultrafiltration of biologics and vaccines.
-
Meningococcal vaccines – global drug forecast and market analysis to 2025
pharmaasia
January 16, 2017
GSK will pass Sanofi as the main provider of meningococcal vaccines in the marketplace by 2025.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
